F2 Bioscience I 2017 Ltd

Insider Reports History

Entity
Company
Location
8, Rue Saint Leger, Geneva, Switzerland
Signature
/s/ Rachel Higham /s/ Ivan Bedford, for F2 Bioscience I 2017 Limited
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by F2 Bioscience I 2017 Ltd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1.31M $16.3M $12.46 Jun 21, 2022 F2 Vision SCS
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1.14M $14.2M $12.46 Jun 21, 2022 By Globeways Holdings Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 622K $7.75M $12.46 Jun 21, 2022 By F2-TPO Investments, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 537K $6.7M $12.46 Jun 23, 2022 Direct
Cullinan Oncology, Inc. 10%+ Owner Common Stock 325K $4.05M $12.46 Jun 21, 2022 By F2 MG Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 215K $2.68M $12.46 Jun 21, 2022 By F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 113K $1.4M $12.46 Jun 21, 2022 By Morana Jovan-Embiricos
Cullinan Oncology, Inc. 10%+ Owner Common Stock 105K $1.31M $12.46 Jun 21, 2022 By F2 GC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 71.6K $892K $12.46 Jun 21, 2022 By F2 Bio TD, LLC

Insider Reports Filed by F2 Bioscience I 2017 Ltd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Jun 21, 2022 3 -$1.3M 4 Jun 23, 2022 10%+ Owner